ABSTRACT
Mendelian randomization (MR) is an analytical approach that uses genetic variants reliably associated with a risk factor of interest to estimate and quantify the causal relationship between exposure and a health related outcome (1, 2) . The method exploits the properties of genetic variation and its validity rests upon three core assumptions: First, the genetic variation is associated with the exposure of interest; second, the genetic variation is independent of any factors that confound the association between the exposure and outcome; third, the genetic variation only influences the outcome via the causal effect of the exposure.
In the form of instrumental variable (IV) analysis, these assumptions can be presented more formally; a genetic variant is a valid instrument for the purposes of estimating the causal effect of an exposure X on an outcome Y if it is: Associated with X (IV assumption 1); independent of all confounders and X and Y, denoted by U (IV assumption 2); and independent of Y given X and U (IV assumption 3) (Figure 1 ). Under these conditions, genetic variants associated with risk factors of interest are independent of other genetic variants and of phenotypes which might confound associations. Furthermore, as the outcome being measured cannot alter germline genotype, any associations observed between the genotype and outcome are unlikely to be affected by reverse causation and other traditional forms of study bias are likely to be avoided (1) . If these assumptions are met then IV analyses (3) can be used to test for a causal relationship between exposure and outcome in observational studies and estimate the magnitude of this causal effect (4, 5) .
A previous study examined the validity of the assumption that there is no association between the genetic IV and confounders of the observational association by testing the association between 23 SNPs (selected on the basis of candidacy for phenotypic association) and 96 phenotypes in >4000 women from the British Women's Heart and Health Study (6) .
Substantial pairwise association was found between phenotypes (i.e. 2036 (45%) associations from 4560 pairwise comparisons met a 1% level of statistical significance when only 45 would be expected by chance alone). In contrast, there was no substantial evidence for inflation in the number of associations between genetic and phenotypic variables (6) . This study supported assertions as to the independence of genetic variation, but it did not use a large and comprehensive list of genetic variants known to be associated with complex traits/diseases that is now available (7) and increasingly used in MR studies.
Over the last decade, the rapid increase in the number of genome wide association studies (GWAS) has produced a large number of single nucleotide polymorphisms (SNPs) that are reliably associated with phenotypes and that might be used to test the causal effect of those phenotypes with disease outcomes. Here our aim was to use all SNPs listed in the NHGRI-EBI GWAS catalog to examine evidence against the assumptions underlying MR. To do this we systematically assessed pairwise associations between a broad collection of phenotypic characteristics that are often considered as outcomes, but also as confounding variables in observational studies and a large number of independent SNPs that are potential IVs in MR studies.
METHODS

Study participants
Genotypic and phenotypic data were from the Avon Longitudinal Study of Parents and Children (ALSPAC), a longitudinal study situated in the South West of England. ALSPAC recruited pregnant women between 1991 and 1992, with over 13,000 live births resulting from these pregnancies. Participants have been followed up with a series of questionnaires, clinic and lab-based assessments over the past 24 years, which has allowed for a wide range of phenotypic and biological measures to be collected. A total of 8,237 of the offspring were available for this study as only those participants with available genetic data (after quality control checks (8, 9) ) were used. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Further information on the recruitment process is documented elsewhere (10, 11) . The study website contains details of all the data that is available through a full searchable data dictionary: www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/.
Phenotypic measurements
The objective of this study was to assess a large set of phenotypes collected from a representative recruitment clinic of the ALSPAC study as a real-world example of a broad phenotypic data set. 121 phenotypic variables (a mixture of binary, continuous and categorical) were taken from clinic-based measurements and self-reported questionnaire data at approximately 7 years (10). This was the first face-to-face contact clinic undertaken within the ALSPAC study and has the largest participant response compared with all other clinic assessments to date. Large prospective cohorts, such as ALSPAC, often have hundreds of thousands of measured characteristics that are potential causal risk factors or confounders in epidemiological analyses. However, these represent a mixture of repeat measurements of the same characteristic (e.g. repeat weight, height and blood pressure at different ages) or measurements that reflect a similar characteristic (e.g. BMI, waist and directly assessed fat mass as measures of adiposity). Since we know that such repeat measurements and different measures of the same thing will be highly correlated we purposely focused on the one assessment at age 7. We did, however, enrich those data with data from prenatal questionnaires, such as family background socioeconomic position and parental behaviors.
As in a previous investigation (6), phenotypes with a known relationship to another were not included, for example, we included diastolic blood pressure and therefore did not include systolic blood pressure. Previous sensitivity analysis demonstrated that the proportion of 'statistically significant' correlations did not change depending on which of these variables were used (6). The full list of phenotypes used in this study is provided in Supplementary   Table 1 .
Genetic data and SNP selection
A set of single nucleotide polymorphisms (SNPs) identified by GWAS as reliably associated with complex phenotypes were obtained from the NHGRI-EBI GWAS catalogue (12) (formerly the NCBI GWAS catalog; accessed 10 th June 2015) and data form them retrieved from ALSPAC participants. These variants were chosen to provide an inclusive list of confirmed GWAS associations that are most likely to be used in MR experiments (13) . We generated an initial list of 17,272 SNPs from 2,154 studies and after removal of duplicate SNPs and those not available in the ALSPAC cohort 14,911 SNPs remained. In ALSPAC data, SNPs were subsequently filtered to MAF>1% and imputation quality score (INFO) > 0.8. Following the removal of SNPs based on these criteria a total 13,720 SNPs remained. All
SNPs were bi-allelic and coded 0, 1 and 2 and analyzed assuming an additive genetic model.
Full information on genetic data and imputation in the ALSPAC cohort is provided in
Supplementary methods.
We also created a dataset of SNPs that were pruned agnostically on the basis of linkage disequilibrium (LD) between them using the --indep-pairwise function in PLINKv1.9 (14) .
This function takes three parameters: (1) window size; (2) step size; and (3) r 2 threshold. LD is calculated for all SNPs within a window (size set to 1500 base pairs) and one SNP in a pair is removed if r 2 >0.2 and the window moved along the chromosome by the "step size" (150 base pairs). This procedure is then repeated. We removed regions with known long range LD (15) generating an LD restricted dataset of 9,684 SNPs.
Statistical analysis
P value summaries of associations within phenotype data and between SNP and phenotype data were derived using a relevant form of regression (linear, logistic or ordinal logistic). The expected number of associations with alpha values of 5%, 1% and 0.01% were obtained by calculating 5%, 1% and 0.01% of the number of pairwise associations tested, respectively.
For all results, inverse log P values (observed and expected) were generated andplots demonstrating the relationship between the observed and expected p value distributions drawn. All statistical analysis was carried out using Stata 13 (16) (commands: "regress", "logistic" and "ologit").
Sensitivity analysis
First, given their potential utility in MR studies, we restricted our pruned set of genetic variants to only those in the NHGRI-EBI GWAS catalog that meet genome-wide significance (P=5x10 -8 ) and tested associations between these and our phenotypic variables as previously reported.
Second, to ensure that any associations observed between phenotypic and genotypic variants were not being inflated by unexpected genotype-genotype correlations, we calculated genotype-genotype correlations for ALSPAC after LD pruning. While biologically one would not expect genotype-genotype correlations of this nature, the presence of these through either mis-mapping, population stratification or chance could potentially complicate MR analyses. This is only a fundamental problem if the same associations were observed across multiple datasets and thus independent MR analyses. We therefore tested for these events in two additional datasets: Wellcome Trust Case Control Consortium (WTCCC) (17) and 1000
Genomes European sample (EUR) (18) . This was done to determine if unexpected genotypegenotype correlations between LD-independent variants were consistent across different datasets or if they were unique. Information on genotyping, quality control and pruning for these two datasets can be found in Supplementary methods. Pearson's correlations for all pairwise combinations of SNPs for each dataset were determined. This analysis was conducted using the R statistical package (19) .
Finally, as a comparator phenotype data set with an enrichment for biomedical and serological measures within the same participants, analyses were undertaken using the same phenotypic variable set used in the UK10K consortium cohorts arm for the ALSPAC collection (20) .
RESULTS
Study description
The sample size of the variables ranged from 1,895 to 6,494 and included a large variety of phenotypic measures including physiological, socioeconomic and behavioral phenotypes at age 7 (Supplementary Table 1 ). A total of 13,720 SNPs were included in the analysis. MAF of these SNPs ranged from 0.01 to 0.50. In the LD restricted dataset, the MAF of 9,684 SNPs ranged from 0.01 to 0.50.
Associations between phenotypes
In a total of 121 phenotypes, 7,260 pairwise comparisons were possible. 2,188 (30%) gave evidence of association where 363 were expected given an alpha level of 5% Figure 3) .
As an indicator of genotype-phenotype associations which would have been followed up in bespoke GWAS efforts in the ALSPAC collection, associations with a P value below the GWAS threshold of P=5x10 -8 were examined in further detail (Supplementary Table 2 ).
rs9568856 (chromosome 13) was associated with both hip circumference and arm circumference. This genetic variant has previously been shown to be associated with body mass index (P = 7.75x10 -5 ) and hip circumference (P = 1.7x10 -5 ) in a large GWAS from The Genetic Investigation of Anthropometric Traits (GIANT) consortium (21, 22) . Additionally, we observed an association between rs4820268 (chromosome 22) and with haemoglobin levels. This genetic variant has previous been shown to be associated with several haematological traits (23), including iron levels (P's = 5.5x10 -7 (24) and 2.4x10 -11 (25) ) and haemoglobin levels (P = 7.4x10 -7 (26)). Of six additional associations, five were observed in strong LD with those identified above and the remaining observed association was between rs2290400 (chromosome 17, trait: Type I diabetes) and asthma. When using a Bonferroni corrected threshold calculated from the number of tests in this specific analysis (P=3.10 -8 ), all but one (the association between rs2290400 and asthma) remained.
Sensitivity analysis
When restricting our SNPs to those in the NHGRI-EBI GWAS catalog that were genomewide significant, 6,175 SNPs were included in the analysis and results were consistent with those reported above (Supplementary Table 3, Supplementary Figure 1) .
We quantified the proportion of genotype-genotype pairs with evidence for association within ALSPAC, EUR and WTCCC, then those pairs with evidence for association in two datasets and those that had evidence for association in all three datasets (Supplementary Figure 2) .
There was some evidence of inflated genotype-genotype correlations in ALSPAC, but only a small proportion of the total number of correlations within genetic variants retained evidence for association after correction for multiple testing (Supplementary Table 4 ) and very few were shared across all three datasets (0.003%).
Analysis undertaken using the same framework, but with an enrichment for biomedical and serological measures showed a relatively small inflation in the number of associations however results were consistent with those reported above (Supplementary Table 5 ).
Results using the biomedical and serological measures only also followed the same patterns of association (Supplementary Table 6 ).
DISCUSSION
By taking a wide selection of phenotypes along with GWAS catalog SNPs we have demonstrated the richness of phenotypic correlation and confirmed the comparatively sparse nature of broadly assessed genotype-phenotype association. More than 30% of pairwise associations between phenotypic characteristics in our dataset showed evidence for association, this empirically supporting the notion that observational epidemiological studies are potentially prone to confounding by physiological, socioeconomic and behavioral characteristics (27, 28) . In contrast to this, only 5.1% of pairwise associations between phenotypic and genotypic characteristics gave evidence for association; a rate closely aligned to chance and likely inflated by real genotype-phenotype association or multiple variables measuring the same biological phenomena (poor measurement). This pattern of association between phenotypic traits and the contrasting pattern between genetic variants selected from GWAS and phenotypic traits was also observed at alpha values of 1% and 0.01% and reflects important properties of genetic variation relevant to causal analyses.
In a previous study, the number of observed associations was 11 times higher than the number of expected associations at the 5% alpha level (6). This is higher than the 6-fold difference observed in this study based on a more comprehensive data set. As the previous study was carried out on older women (aged between 60 and 79), this difference may reflect the fact that in general phenotypes become more correlated with increasing age as a result of exposure to overarching networks of environmental confounders. Despite this difference, our results highlight the marked inflation in correlation between phenotypic measurements and hence the difficulty in studies using multivariable regression approaches to be confident that residual or unmeasured confounding does not yield exaggerated or attenuated results (29) .
This study provides support for the second assumption of MR analyses -that genotype is not associated with factors that confound the relationship between the exposure and the outcome -but has limitations. Despite patterns observed here, it remains important to check that genetic instruments are not related to observed potential confounders in MR studies; an event which could theoretically be driven by specific instances of population stratification or chance. In addition, this study was not explicitly designed to address the presence of horizontal/true pleiotropy, which is often analytically indistinguishable from vertical pleiotropy or pathway effects (30) . It is possible that the observed inflation in the number of observed genotype/phenotype associations is predominantly driven by vertical/pathway based associations and results from the more biomedically aligned phenotype panel may be considered in line with this. However, we urge caution in MR analyses in the absence of testing this interpretation formally. Indeed, whilst the SNPs found in this study that might be considered as potentially valid instruments for MR analysis (i.e. those meeting genomewide significance, p=5x10 -8 ) only had 1 trait association each, in more comprehensive analyses, shared genetic contributions to phenotypes of interest were prevalent (31) . These extent of these types of event are of course subject to the statistical performance of the study in question, but are presented to illustrate that even with the contrasting scale of variable correlation in genotypic data, the underpinnings of applied genotypic data should be explored or accounted for.
We strongly support the use of methods attempting to account for events like genetic confounding (pleiotropy) that can distort causal estimates. This is especially true given the trend for using large collections of potentially invalid instruments in polygenic risk score based analyses (20) . MR-Egger regression and the weighted median approach (32, 33) are promising developments and able to estimate causal effects in the presence of pleiotropic instruments (32) . These approaches require additional assumptions about the nature of pleiotropy to be made and provide causal estimates with a reduced precision, however are
likely to give refinement to this paradigm of natural experimentation (34) which might otherwise suffer from inevitable limitations of its own design. This serves as a reminder of the utility of MR as providing an important contribution to the evidence base as opposed to a definitive answer (35) .
In conclusion, this study has reaffirmed our understanding of the extensive patterns of correlation seen between non-genetic traits. In a systematic manner and pertinent to the explosion of MR use and methods development currently, it has also shown that this is not the case for correlations between genetic variants and phenotypes. This provides further support for the use of genetic variants as IVs in MR studies as they are unlikely to generally strongly violate the assumptions that IVs are not related to confounders of the observational association. 
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Figure 3. QQ plots of genotypic and phenotypic associations
Left: QQ plot of observed associations between 13,720 NHGRI-EBI-GWAS catalog SNPs (All SNPs) and 121 phenotypes included in analysis against expected P values. Right: QQ plot of observed associations between 9,684 NHGRI-EBI GWAS catalog SNPs pruned for LD and 121 phenotypes included in analysis against expected P values. Inverse log of P values is the -log10 P value.
